This website is for UK Healthcare Professionals only

ASH 2021 - The 63rd American Society of Haematology Annual Meeting and Exposition

About the latest data for VENCLYXTO® in Acute Myloid Leukaemia (AML)

To receive the latest AbbVie information on upcoming congresses


On demand: Access content from ASH 2021

Dr Steve Knapper and Dr Richard Dillon

Insights from ASH 2021:
Acute Myeloid Leukaemia

Dr Steve Knapper and Dr Richard Dillon review the findings of VIALE-A trial study

 

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk.

Adverse events should also be reported to AbbVie on GBPV@abbvie.com

UK-VNCAML-220028. Date of Preparation: April 2022.